Intelligence · Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.
-
Short Cycle Antiretroviral Therapy
BRIGHT MINDS BIOSCIENCES INC.
HIV Infections
1 trial -
Sitagliptin 50mg Film-coated Tablets, Trajenta 5 mg film-coated tablets, Pioglitazone Mylan 15 mg compresse, Ozempic 0.5 mg solution for injection in pre-filled pen, Jardiance 10 mg film-coated tablets, GLUCOPHAGE 1000 mg potahované tablety, Invokana 100 mg film-coated tablets, Trulicity 1.5 mg solution for injection in pre-filled pen, Galvus 50 mg tablets, Forxiga 10 mg film-coated tablets
The George Institute
Type 2 Diabetes Mellitus
1 trial -
Skin stretching device (SSD)
The First People's Hospital of Lianyungang
Trauma
1 trial -
Sodium Chloride 0.9%, Gardasil 9 suspension for injection. Human Papillomavirus 9-valent Vaccine (Recombinant, adsorbed)
Disc Medicine
Vulvar High-Grade Squamous Intraepithelial Lesion (vHSIL)
1 trial -
Sodium Chloride Fresenius Kabi Italia 0,9 % Solution for infusion, MabThera 500 mg concentrate for solution for infusion
Disc Medicine
Systemic sclerosis
1 trial -
Sodium Chloride Fresenius Kabi Italia 0.9 % Solution for infusion , DENOSUMAB, Sodium Fluoride (18F) Life Radiopharma 0,1 - 4 GBq/ml solution injectable
Disc Medicine
Fibrous dysplasia/McCune-Albright syndrome
1 trial -
Sodium Oxybate
Jazz Pharmaceuticals Ireland Limited
REM Sleep Behavior Disorder
1 trial -
Sodium valproate
Chinese University of Hong Kong
Epilepsy
1 trial -
Sofosbuvir / Velpatasvir Oral Tablet [Epclusa]
BRIGHT MINDS BIOSCIENCES INC.
HEPATITIS C (HCV)
1 trial -
Solriamfetol
Axsome Therapeutics
Excessive Daytime Sleepiness
1 trial -
Solriamfetol Oral Tablet
Axsome Therapeutics
Excessive Sleepiness
1 trial -
Songling Xuemaikang Capsules
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Hypertension,Essential
1 trial -
Sorvasta 20 mg filmsko obložene tablete, Sorvitimb 20 mg/10 mg filmsko obložene tablete, Sorvasta 10 mg filmsko obložene tablete, Sorvasta 40 mg filmsko obložene tablete, Sorvitimb 40 mg/10 mg filmsko obložene tablete
Novo Nordisk A/S
Hyperlipidaemia
1 trial -
Sovaldi 400 mg film-coated tablets
Disc Medicine
Healthy volunteers
1 trial -
Spikevax 50 micrograms dispersion for injection in pre-filled syringe COVID-19 mRNA Vaccine
Moderna Biotech Spain
SARS-CoV-2 infection
1 trial -
Standard BP control
The First People's Hospital of Lianyungang
Hypertension
1 trial -
Statin
The First People's Hospital of Lianyungang
Acute Coronary Syndrome
1 trial -
Subcutaneous HYLENEX (recombinant human hyaluronidase) and Lactated Ringer's solution
HALOZYME THERAPEUTICS, INC.
Dehydration
1 trial -
Sufentanil
The First People's Hospital of Lianyungang
Arteriovenous Malformation
1 trial -
Sugammadex hameln 100 mg/ml oplossing voor injectie, Naloxon HCl Accord 0,4 mg/ml, oplossing voor injectie / infusie in een voorgevulde spuit, ANEXATE 0,5 mg/5 ml, solution injectable (I.V.), REMIMAZOLAM , Sufentanil Viatris 5 microgram/ml oplossing voor injectie, Esmeron 10 mg/ml, oplossing voor injectie
Disc Medicine
General anesthesia
1 trial -
Sulfato de Magnesio Altan 150 mg/ml solución inyectable y para perfusión EFG, LIDOCAINE HYDROCHLORIDE, Dexdor 100 micrograms/ml concentrate for solution for infusion, KETOLAR 50 mg/ml solución inyectable.
The George Institute
Obesity
1 trial -
Surabgene Lomparvovec (ABBV-RGX-314), Lucentis 10 mg/ml solution for injection in pre-filled syringe, Surabgene Lomparvovec (ABBV-RGX-314)
AbbVie Deutschland GmbH & Co. KG
Neovascular age-related macular degeneration
1 trial -
Surgical tumor resection, GammaTile radiation therapy implantation, Stupp protocol (EBRT and Temozolamide)
GT Biopharma
Glioblastoma
1 trial -
Symbicort Turbuhaler (budesonide/formoterol) 320/9 μg
AstraZeneca
Chronic Obstructive Pulmonary Disease (COPD)
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources